Trial Profile
A Phase 2, Double-Blind, Randomized, 4-Arm, Controlled, Multi-Center Study to Evaluate the Efficacy and Safety of a Single Dose of RT001 Topical Gel for the Treatment of Moderate to Severe Lateral Canthal Lines in Adults
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 31 Oct 2014
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Facial wrinkles
- Focus Therapeutic Use
- Sponsors Revance Therapeutics
- 31 Oct 2014 New trial record